Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Andy Biotech is a biotechnology enterprise specializing in the research, development, and production of natural plant extracts and active herbal ingredients. Based in Xi'an, China, the company serves the global pharmaceutical, nutraceutical, and cosmetic industries by providing high-purity botanical derivatives such as resveratrol, icariin, and various fruit and vegetable powders. The company operates advanced manufacturing facilities that adhere to international quality standards, including GMP, ISO, and Halal certifications. Andy Biotech focuses on providing high-quality raw materials and contract manufacturing services to support the formulation of health supplements and functional foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ANDY BIOTECH.